Circulars

Circular – Govt, DCGI

Govt. / CDSCO issues notices / circulars time to time for stake holders and the same are uploaded on official website of CDSCO.

We have provided some of the important notices / circulars relevant to the above said topic, Click below links for more information:

2020

DCGI Order dt 28-12-2020 – Regulation of Blood Glucose monitors Blood pressure monitors Nebulizers and Thermometers as drugs with effect from Jan 1st 2021

DCGI Notice dt 17-9-2020 – regarding import of drug & related product

DCGI Circular 08-09-2020 – regarding 294 rational FDCs – procedure to be followed

DCGI Notice dt 03-09-2020 – Classification 24 categories of MD – reference SO 648(E) and GSR 102(E) dated 11-02-2020

DCGI Notice dt 03-09-2020 – Classification of 3 Categories of MD IVDs – reference SO 648(E) and GSR 102(E) dated 11-02-2020

DCGI Notice dt. 31-08-2020 – requirement of fees for change in address of authorized agent under MDR 2017

DCGI Notice dt 31-08-2020 – Submission of notarized documents for import of medical devices and In-Vitro kits in view of Covid-19

ICMR 14-08-2020 List-of companies vendors of Rapid antigen test kits for Covid-19 validated or being validated

ICMR on 04-05-2020 shortlisted 21 hospitals for Plasma trial, 90 hospitals are in queue

DCGI Letter 01-05-2020 – regarding extension of validity of WHO-GMP / CoPP

DCGI Circular 30-04-2020 – regarding extension of validity of BA/BE study centres

DCGI approval 17-04-2020 – Rapid, CLIA, ELISA kits approved for testing of Covid-19 with the condition

DCGI Notice 17-04-20 Clinical trial of convalescent plasma in COVID-19 Patients

DCGI letter 16-04-20 along with list of 55 critical medicines for Covid-19

DCGI letter 07-04-2020 Regarding granting permission to-manufacture Medical gas by Industrial gases plant

ICMR Press release 06-04-2020 ICMR scales up its capacity to fight COVID-19

Govt of India has issued a mannual on hand made mask 30-03-2020

ICMR Press release 23-03-2020 Fast Track Approval for Indian COVID-19 testing kits for commercial use

ICMR Press release 17-03-2020 ICMR enables more laboratories to test for COVID-19 and revises the criteria

DCGI Notice 13-03-20 – Guidelines for approval of synthetically manufactured drugs which has been previously approved as r-DNA derived drug

DCGI Notice 13-03-20 – Requirement of CMC documents for approval of additional indication of an already approved drug product

DCGI Notice 13-03-20 – Requirement of process validation report for permission to conduct Clinical trial / BA-BE studies

DCGI Notice 13-03-20 – Testing of all categories of new drugs for their approval

DCGI has issued circular on 04-03-2020 Regarding – Disposal of the applications of “Written confirmation” for active substances exported to the EU for medicinal products for human use in accordance with Article 46(2) (b) of Directive No. 2001/83/EC.

DCGI has issued circular on 03-03-2020 regarding disposal applications of WHO-GMP, Certificate of Pharmaceutical Products (CoPP)

DCGI has issued notice on 26-02-2020 regarding submission and processing of application for registration certificate and import license in parallel with new drug application

DCGI has issued notice on 21-02-2020 regarding approval of FDCs containing new drugs

DCGI has issued notice on 21-02-2020 regarding fixing of limit of impurities in the specifications of INDs

DCGI has issued notice on 21-02-2020 regarding permission to conduct BA BE studies and clinical trial

DCGI has issued notice on 21-02-2020 regarding pre-submission meeting for new drugs and clinical trials

DCGI has issued notice on 21-02-2020 regarding Processing of application for BA BE permission issued in Form CT-07 import license issued in CT-17

DCGI has issued notice on 21-02-2020 regarding requirements of stability data for CoPPs

DCGI has issued notice on 21-02-2020 regarding stability data for BA BE study in human for export

DCGI has issued notice on 21-02-2020 regarding sub acute toxicity study report for injectable products for BA BE study in human for export

DCGI has issued notice on 20-02-2020 regarding Considerations-of Honb’le Supreme Court of India in the case of 294 FDCs

DCGI has issued notice on 07-02-2020 regarding Pathway for subsequent manufacture of category d FDCs as per Prof. Kokate Committee Report-extension in time limit for submission of application

DCGI has issued a notice 27-01-2020 regarding Processing of post approval to BA BE permission issued in Form CT-07, import license issued in CT-17

DCGI has issued a notice 22-01-2020 regarding – List of Reference Products for Conduct of BE Study. Click below for more information:

Ministry of Health has issued a notice on 16-01-2020 for seeking comments / objections / suggestions on the proposal of framing recruitment Rules for Drugs Inspector ( Medical Device). To download the said notice, click below link:

DCGI has issued a notice 08-11-2019 regarding clarification on exemption of sale license for importer of X Ray, MRI, PET, Ultrasound, CT Scan machine etc. Click below for more information:

2019

DCGI has issued a notice 08-11-2019 regarding clarification on Implantable Medical Devices. Click below for more information:

DCGI has issued a notice 08-11-2019 regarding clarification regarding environmental conditions for equipments. Click below for more information:

Directions by Health Ministry dated 09-11-2012 under Sec 33(P) of D&C Act for drug formulation in proper or generic name only

DCGI Circular 05-07-2019 – Monitoring the end use of drugs which are meant for dual use

Directions by Health Ministry dated 01-10-2012 under Sec 33(P) of D&C Act for drug formulation in proper or generic name only

Popular posts

The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.

Follow and connect with us on Facebook and Linkedin

Go to main website, click here

Subscribe for daily free updates, click here